UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

Therapeutic advances in medical oncology, 2022-02, Vol.14, p.17588359221079125-17588359221079125

2022

Volltextzugriff (PDF)

Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer

Therapeutic Advances in Medical Oncology, 2022-01, Vol.14, p.17588359221144099-17588359221144099

2022

Volltextzugriff (PDF)

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review

International journal of cancer, 2019-09, Vol.145 (5), p.1179-1188

2019

Volltextzugriff (PDF)

Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies

Cancer treatment reviews, 2018-04, Vol.65, p.1-10

2018

Volltextzugriff (PDF)

Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy

Therapeutic advances in medical oncology, 2022-01, Vol.14, p.17588359221141761-17588359221141761

2022

Volltextzugriff (PDF)

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion–Driven NSCLC

Cancer discovery, 2020-08, Vol.10 (8), p.1194-1209

2020

Volltextzugriff (PDF)

Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer

Scientific reports, 2020-01, Vol.10 (1), p.643-643, Article 643

2020

Volltextzugriff (PDF)

Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma

Clinical cancer research, 2021-08, Vol.27 (15), p.4397-4409

2021

Volltextzugriff (PDF)

Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives

Immune Network, 2020, 20(1), , pp.1-14

2020

Volltextzugriff (PDF)

Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions

Lung cancer (Amsterdam, Netherlands), 2018-01, Vol.115, p.12-20

2018

Volltextzugriff (PDF)

Effect of glycopyrrolate versus atropine coadministered with neostigmine for reversal of rocuronium on postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: a prospective randomized study

Journal of anesthesia, 2015-12, Vol.29 (6), p.831-835

2015

Volltextzugriff (PDF)

Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience

Cancer Immunology, Immunotherapy, 2022-05, Vol.71 (5), p.1093-1101

2022

Volltextzugriff (PDF)

Genomic landscape of extraordinary responses in metastatic breast cancer

Communications biology, 2021-04, Vol.4 (1), p.449-449, Article 449

2021

Volltextzugriff (PDF)

Association between Obesity Indices and Insulin Resistance among Healthy Korean Adolescents: The JS High School Study

PloS one, 2015-05, Vol.10 (5), p.e0125238-e0125238

2015

Volltextzugriff (PDF)

Patritumab Deruxtecan: Paving the Way for EGFR-TKI-Resistant NSCLC

Cancer discovery, 2022-01, Vol.12 (1), p.16-19

2022

Volltextzugriff (PDF)

Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma

Frontiers in immunology, 2021-02, Vol.12, p.598671-598671

2021

Volltextzugriff (PDF)

Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements

PloS one, 2014-07, Vol.9 (7), p.e103333-e103333

2014

Volltextzugriff (PDF)

Advances in the management of non-small-cell lung cancer harbouring EGFR exon 20 insertion mutations

Therapeutic Advances in Medical Oncology, 2023-01, Vol.15, p.17588359221146131-17588359221146131

2023

Volltextzugriff (PDF)

Management of HER2 alterations in non-small cell lung cancer – The past, present, and future

Lung cancer (Amsterdam, Netherlands), 2023-12, Vol.186, p.107385-107385, Article 107385

2023

Volltextzugriff (PDF)

Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models

Lung cancer (Amsterdam, Netherlands), 2019-01, Vol.127, p.112-121

2019

Volltextzugriff (PDF)

Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer

Journal of clinical oncology, 2013-02, Vol.31 (6), p.731-737

2013

Volltextzugriff (PDF)

The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges

Frontiers in oncology, 2022-03, Vol.12, p.811247-811247

2022

Volltextzugriff (PDF)

Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial

Nature communications, 2023-11, Vol.14 (1), p.7301-7301, Article 7301

2023

Volltextzugriff (PDF)

Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors

Cancer research (Chicago, Ill.), 2018-06, Vol.78 (12), p.3350-3362

2018

Volltextzugriff (PDF)

Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing

PloS one, 2024-02, Vol.19 (2), p.e0294857-e0294857

2024

Volltextzugriff (PDF)

1 – 25 von 3.763

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.550)
Mit Volltextzugriff
(3.188)

Publikationsform

Artikel
(2.968)
Buchkapitel
(719)
Tagungsberichte
(59)
Berichte
(11)
Bücher
(6)

Sprache

Englisch
(3.382)
Koreanisch
(358)
Japanisch
(19)
Deutsch
(2)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.981)
Life Sciences & Biomedicine
(1.366)
Humans
(756)
Male
(484)
Technology
(482)
Female
(473)
Middle Aged
(352)
Engineering
(343)
Animals
(285)
Aged
(264)
Adult
(253)
Physical Sciences
(246)
Engineering, Civil
(240)
Oncology
(237)
Original
(199)
Chemistry
(185)
Science & Technology - Other Topics
(160)
Mice
(152)
Materials Science
(149)
Biochemistry & Molecular Biology
(142)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review

Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies

Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion–Driven NSCLC

Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer

Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma

Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives

Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions

Effect of glycopyrrolate versus atropine coadministered with neostigmine for reversal of rocuronium on postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: a prospective randomized study

Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience

Genomic landscape of extraordinary responses in metastatic breast cancer

Association between Obesity Indices and Insulin Resistance among Healthy Korean Adolescents: The JS High School Study

Patritumab Deruxtecan: Paving the Way for EGFR-TKI-Resistant NSCLC

Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma

Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements

Advances in the management of non-small-cell lung cancer harbouring EGFR exon 20 insertion mutations

Management of HER2 alterations in non-small cell lung cancer – The past, present, and future

Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models

Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer

The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges

Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial

Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors

Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing

Suchergebnisse filtern